Condition: Head and Neck Carcinoma · Adenoid Cystic Carcinoma · Lung Cancer · Sponsor: VM Oncology, LLC
This is a multicenter, open-label, Phase 1/2 study of orally administered VMD-928 monotherapy and in combination with pembrolizumab in adult subjects with advanced solid tumors or lymphoma that have progressed or are non responsive to available therapies and for which no standard or available curative therapy exists
This description comes directly from the study's public registry record.
Jay Wu, PhD · 1-510-270-2790 · OM@VMOncology.com
Always discuss trial participation with your own doctor first.
| Providence Medical Foundation (site 209) | Santa Rosa, California, United States | Recruiting |
| Hartford Hospital (site 210) | Hartford, Connecticut, United States | Recruiting |
| The George Washington University Cancer Center (site 212) | Washington D.C., District of Columbia, United States | Recruiting |
| Holy Cross Hospital (site 213) | Fort Lauderdale, Florida, United States | Recruiting |
| Memorial Cancer Institute at Memorial Healthcare Systems (site 132) | Pembroke Pines, Florida, United States | Recruiting |
| Englewood Hospital and Medical Center (site 202) | Englewood, New Jersey, United States | Recruiting |
| Summit Medical Group (site 205) | Florham Park, New Jersey, United States | Recruiting |
| Atlantic Health System, Morristown Medical Center (site 124) | Morristown, New Jersey, United States | Recruiting |
| Presbyterian Kaseman Hospital (site 208) | Albuquerque, New Mexico, United States | Recruiting |
| Weill Cornell Medicine, Cornell University (site 126) | New York, New York, United States | Recruiting |
| Taylor Cancer Research Center (site 204) | Maumee, Ohio, United States | Recruiting |
| Cancer Care Associates of York (site 206) | York, Pennsylvania, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03556228